Name: Apogee Therapeutics, Inc. (APGE) Balance Sheet
Creator: FinSpry

Apogee Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Apogee Therapeutics, Inc. (APGE) - Annual data in billions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	0.14	0.12	0.15
Short-Term Investments	0.38	0.28	0.00
Cash & Short-Term Investments	0.52	0.40	0.15
Accounts Receivable	0.00	0.00	0.00
Inventory	0.00	0.00	0.00
Other Current Assets	0.00	0.00	0.00
Total Current Assets	0.53	0.40	0.15
Non-Current Assets
Property, Plant & Equipment (Net)	0.01	0.00	0.00
Long-Term Investments	0.21	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00
Total Non-Current Assets	0.22	0.00	0.00
Total Assets	0.75	0.40	0.15
Current Liabilities
Accounts Payable	0.00	0.00	0.00
Short-Term Debt	0.00	0.00	0.00
Accrued Liabilities	0.02	0.02	0.01
Other Current Liabilities	0.02	0.00	0.00
Total Current Liabilities	0.03	0.02	0.01
Non-Current Liabilities
Long-Term Debt	0.01	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00
Total Non-Current Liabilities	0.01	0.00	0.00
Total Liabilities	0.04	0.02	0.01
Stockholders' Equity
Common Stock	0.00	0.00	0.00
Retained Earnings	-0.31	-0.12	-0.04
Accumulated Other Comprehensive Income	0.00	0.00	0.00
Additional Paid-in Capital	1.02	0.50	0.00
Shares Outstanding	0.06	0.05	0.05
Total Stockholders' Equity	0.72	0.38	0.14
Total Liabilities & Equity	0.75	0.40	0.15